Triple

T15478688
Position Surface form Disambiguated ID Type / Status
Subject kynurenine pathway E376854 entity
Predicate rateLimitingEnzyme P118413 FINISHED
Object indoleamine 2,3-dioxygenase 1
Indoleamine 2,3-dioxygenase 1 is an immune-regulatory enzyme that catalyzes the initial oxidative degradation of tryptophan along the kynurenine pathway, influencing inflammation, tolerance, and tumor immune evasion.
E1160708 NE FINISHED

How this triple was built (5 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: indoleamine 2,3-dioxygenase 1 | Statement: [kynurenine pathway, rateLimitingEnzyme, indoleamine 2,3-dioxygenase 1]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: indoleamine 2,3-dioxygenase 1
Context triple: [kynurenine pathway, rateLimitingEnzyme, indoleamine 2,3-dioxygenase 1]
  • A. indoleamine 2,3-dioxygenase 2
    Indoleamine 2,3-dioxygenase 2 is an immune-regulatory heme-containing enzyme that catalyzes the oxidative degradation of tryptophan along the kynurenine pathway, influencing inflammation and immune tolerance.
  • B. tryptophan 2,3-dioxygenase
    Tryptophan 2,3-dioxygenase is a heme-containing enzyme that catalyzes the first and rate-limiting step in the oxidative degradation of tryptophan, playing a key role in tryptophan metabolism and regulation.
  • C. kynurenine aminotransferase II
    Kynurenine aminotransferase II is a pyridoxal phosphate-dependent enzyme that converts kynurenine to kynurenic acid, a neuroactive metabolite implicated in brain function and neurodegenerative disorders.
  • D. kynureninase
    Kynureninase is a pyridoxal phosphate-dependent enzyme that catalyzes key steps in tryptophan degradation within the kynurenine pathway, contributing to the production of NAD⁺ and other metabolites.
  • E. aromatic L-amino acid decarboxylase
    Aromatic L-amino acid decarboxylase is a pyridoxal phosphate–dependent enzyme that catalyzes the decarboxylation of aromatic L-amino acids to produce key neurotransmitters such as dopamine and serotonin.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: indoleamine 2,3-dioxygenase 1
Triple: [kynurenine pathway, rateLimitingEnzyme, indoleamine 2,3-dioxygenase 1]
Generated description
Indoleamine 2,3-dioxygenase 1 is an immune-regulatory enzyme that catalyzes the initial oxidative degradation of tryptophan along the kynurenine pathway, influencing inflammation, tolerance, and tumor immune evasion.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: indoleamine 2,3-dioxygenase 1
Target entity description: Indoleamine 2,3-dioxygenase 1 is an immune-regulatory enzyme that catalyzes the initial oxidative degradation of tryptophan along the kynurenine pathway, influencing inflammation, tolerance, and tumor immune evasion.
  • A. indoleamine 2,3-dioxygenase 2
    Indoleamine 2,3-dioxygenase 2 is an immune-regulatory heme-containing enzyme that catalyzes the oxidative degradation of tryptophan along the kynurenine pathway, influencing inflammation and immune tolerance.
  • B. tryptophan 2,3-dioxygenase
    Tryptophan 2,3-dioxygenase is a heme-containing enzyme that catalyzes the first and rate-limiting step in the oxidative degradation of tryptophan, playing a key role in tryptophan metabolism and regulation.
  • C. kynurenine aminotransferase II
    Kynurenine aminotransferase II is a pyridoxal phosphate-dependent enzyme that converts kynurenine to kynurenic acid, a neuroactive metabolite implicated in brain function and neurodegenerative disorders.
  • D. kynureninase
    Kynureninase is a pyridoxal phosphate-dependent enzyme that catalyzes key steps in tryptophan degradation within the kynurenine pathway, contributing to the production of NAD⁺ and other metabolites.
  • E. aromatic L-amino acid decarboxylase
    Aromatic L-amino acid decarboxylase is a pyridoxal phosphate–dependent enzyme that catalyzes the decarboxylation of aromatic L-amino acids to produce key neurotransmitters such as dopamine and serotonin.
  • F. None of above. chosen
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: rateLimitingEnzyme
Context triple: [kynurenine pathway, rateLimitingEnzyme, indoleamine 2,3-dioxygenase 1]
  • A. enzymeType
    Indicates the specific class or category of enzyme associated with an entity or reaction.
  • B. supportsRateLimiting
    Indicates that one entity provides or is compatible with mechanisms to restrict the rate at which another entity can perform actions or process requests.
  • C. aimedToLimit
    Indicates an action or policy that was intentionally directed toward restricting, reducing, or constraining something.
  • D. enzymeSystem
    Indicates a relationship where an entity functions as, or is part of, a specific enzyme system involved in catalyzing biochemical reactions.
  • E. isMetabolizedBy
    Indicates that a substance is biochemically broken down or transformed through metabolic processes carried out by a specified organism, cell type, or enzyme system.
  • F. None of above. chosen

Provenance (7 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d85cd21dcc81908646251b1c26ea00 completed April 10, 2026, 2:13 a.m.
NER Named-entity recognition batch_69e03f8a77a081909f12f13660452f4a completed April 16, 2026, 1:46 a.m.
NED1 Entity disambiguation (via context triple) batch_69ff36595bfc8190a0d60b3cb875ccc5 completed May 9, 2026, 1:27 p.m.
NEDg Description generation batch_69ff376dac388190ab3b7e3553d2de29 completed May 9, 2026, 1:32 p.m.
NED2 Entity disambiguation (via description) batch_69ff382f1bbc8190810d0d825430f9ea completed May 9, 2026, 1:35 p.m.
PD Predicate disambiguation batch_69ded2874b788190999158e0f043be21 completed April 14, 2026, 11:49 p.m.
PDg Predicate description generation batch_69ded5deee00819099fa3e43313312e1 completed April 15, 2026, 12:03 a.m.
Created at: April 10, 2026, 3:34 a.m.